Paxlovid treatment does not reduce risk of long COVID, study finds

Source link: https://www.sciencedaily.com/releases/2024/01/240104121836.htm

A team of researchers has found that Paxlovid (Nirmatrelvir-ritonavir) did not reduce the risk of developing long COVID for vaccinated, non-hospitalized individuals during their first COVID-19 infecti ...

Beware!

This is a preview of the article. To access the full text click on the source link or Sign In.